A Prospective, Randomized, Active-controlled, Parallel, Open, Multi-center, Phase IV, Exploratory Clinical Trial to Compare the Effects of Improving the Carotid Artery Intima Media Thickness and Changing Lipid Levels by Cilostazol/Ginkgo Leaf Extract (Renexin CR) and Aspirin (Aspirin Protect Tab.) in Diabetic Peripheral Angiopathy.
Latest Information Update: 17 Mar 2025
At a glance
- Drugs Cilostazol/ginkgo biloba (Primary) ; Aspirin
- Indications Diabetic angiopathies
- Focus Therapeutic Use
- Sponsors SK Chemicals
Most Recent Events
- 12 Mar 2025 Status changed from recruiting to completed.
- 20 Jun 2023 New trial record